分享产品介绍 评论(0)
产品规格
抗体类型
ADC抗体同种型
Human IgG1, κ同型对照
Invivo human IgG1 isotype control浓度
1 mg/ml纯度
>95% (Determined by SDS-PAGE)内毒素含量
<1EU/mg性状
Liquid缓冲体系
Reconstitute the Trastuzumab deruxtecan using 0.9% Sodium Chloride Injection
储存条件
2 to 8 °C for 2 weeks under sterile conditions;
-20 °C for 3 months under sterile conditions;
-80 °C for 24 months under sterile conditions.
Please avoid repeated freeze-thaw cycles.
背景介绍
Trastuzumab deruxtecan (DS-8201a) is an anti-human epidermal growth factor receptor 2 (HER2) antibody-drug conjugate (ADC). Trastuzumab deruxtecan is composed of a humanized anti-HER2 antibody, an enzymatically cleavable peptide-linker, a topoisomerase I inhibitor (a toxin component of Dxd). Trastuzumab deruxtecan can be used for the research of HER2-positive breast cancer and gastric cancer.
评论(0)